Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia

被引:113
作者
Marks, KA
Fastenau, PS
Lysaker, PH
Bond, GR
机构
[1] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA
[2] Rondebush VA Med Ctr 116H, Dept Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Indianapolis, IN USA
关键词
insight; schizophrenia; neuropsychological assessment; cognition;
D O I
10.1016/S0920-9964(99)00208-X
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The Self-Appraisal of Illness Questionnaire (SAIQ) is a self-report instrument designed to assess attitudes toward mental illness among persons receiving psychiatric treatment. This instrument was developed for use in community settings, adapted closely from the Patient's Experience of Hospitalization questionnaire. In order to examine the validity of the SAIQ, a factor analysis was first conducted on the items of this instrument in a sample of 59 outpatients with schizophrenia or schizoaffective illness. Three factors emerged: Need for Treatment, Worry, and Presence/Outcome of Illness. Next, to examine the concurrent validity of these three SAIQ subscales, they were correlated with researcher rated insight scales and neuropsychological tests. Results indicated that the Need for Treatment and Presence/Outcome subscales were significantly correlated with both researcher-rated insight scales and with neuropsychological tests of executive functioning. The Worry subscale was not associated with either researcher-rated insight scales or neuropsychological tests. It was concluded that the Need for Treatment and Presence/Outcome subscales may be used in combination as a brief screening instrument for clients with schizophrenia receiving outpatient psychiatric treatment who may be at risk for treatment non-compliance due to a lack of insight into illness. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:203 / 211
页数:9
相关论文
共 28 条
[1]   AWARENESS OF ILLNESS IN SCHIZOPHRENIA [J].
AMADOR, XF ;
STRAUSS, DH ;
YALE, SA ;
GORMAN, JM .
SCHIZOPHRENIA BULLETIN, 1991, 17 (01) :113-132
[2]  
AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826
[3]   THE POSITIVE AND NEGATIVE SYNDROME SCALE AND THE BRIEF PSYCHIATRIC RATING-SCALE - RELIABILITY, COMPARABILITY, AND PREDICTIVE-VALIDITY [J].
BELL, M ;
MILSTEIN, R ;
BEAMGOULET, J ;
LYSAKER, P ;
CICCHETTI, D .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1992, 180 (11) :723-728
[4]  
Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]
[5]   A 2-YEAR PROSPECTIVE-STUDY OF TREATMENT COMPLIANCE IN PATIENTS WITH SCHIZOPHRENIA [J].
BUCHANAN, A .
PSYCHOLOGICAL MEDICINE, 1992, 22 (03) :787-797
[6]   THE PEH - A QUESTIONNAIRE TO ASSESS ACKNOWLEDGMENT OF PSYCHIATRIC-ILLNESS [J].
CARSKY, M ;
SELZER, MA ;
TERKELSEN, K ;
HURT, SW .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1992, 180 (07) :458-464
[7]   INSIGHT AND PSYCHOSIS [J].
DAVID, AS .
BRITISH JOURNAL OF PSYCHIATRY, 1990, 156 :798-808
[8]  
Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159
[9]  
Golden C. J., 1978, STROOP COLOR WORD TE
[10]   DEVELOPMENT AND VALIDATION OF A MODEL FOR ESTIMATING PREMORBID VERBAL INTELLIGENCE IN THE ELDERLY [J].
GROBER, E ;
SLIWINSKI, M .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1991, 13 (06) :933-949